|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Lung Disease | |||||
| Hypoxemia | |||||
| Respiratory Acidosis | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Acidosis | |||||
| Acidosis, Respiratory | |||||
| Lung Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Acid-Base Imbalance | |||||
| Metabolic Diseases | |||||
| Respiration Disorders | |||||
| Respiratory Insufficiency | |||||
| Respiratory Tract Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| nitric oxide for inhalation | |||||
| Oxygen | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| Nitric Oxide | |||||
| 6 | More general drug interventions related to this trial | ||||
| Anti-Asthmatic Agents | |||||
| Antioxidants | |||||
| Autonomic Agents | |||||
| Bronchodilator Agents | |||||
| Cardiovascular Agents | |||||
| Endothelium-Dependent Relaxing Factors | |||||
| Free Radical Scavengers | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Protective Agents | |||||
| Respiratory System Agents | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 7 | Sponsors listed in this trial | ||||
| INO Therapeutics | |||||